Top Markets
Coin of the day
Orexo AB Orexo AB

Orexo AB

ORX
株式のランク #24940
Orexo AB (publ), a specialty pharmaceutical company, develops and... Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; and OX-MPI for the treatment of endometriosis. Its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.
株価
$1.56
時価総額
$54.85M
変化(1日)
-0.29%
変化(1年)
-29.14%
SE
取引 Orexo AB (ORX)

カテゴリー

Orexo AB(ORX)の配当利回りの履歴
Orexo AB(銘柄コード: ORX)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Orexo AB(ORX)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)